BAYZED HEALTH (02609) announced that according to the quarterly review results of the Hang Seng Index series released by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng Index series components, effective from September 8, 2025.

The indices include but are not limited to: Hang Seng Composite Index; Hang Seng Composite Industry Index - Healthcare; Hang Seng Composite MidCap & SmallCap Index; Hang Seng Composite SmallCap Index; Hang Seng Healthcare Index; Hang Seng Stock Connect Healthcare Equipment & Services (Investable) Index; and Hang Seng Stock Connect Healthcare Equipment & Services Index.

The Hang Seng Composite Index covers 95% of the total market capitalization of companies listed on the Main Board of The Stock Exchange of Hong Kong Limited, providing a comprehensive benchmark for the Hong Kong market. The index serves as a foundation for launching index funds, mutual funds, and performance measurement benchmarks.

Inclusion in the Hang Seng Composite Index will make the company's shares eligible for trading through Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, which are trading channels between Hong Kong and mainland China investors.

The Board of Directors believes that the company's inclusion in the Hang Seng Composite Index and the aforementioned indices reflects increased investor recognition of the group's operating performance, investment value, and development potential. This is expected to enhance the company's visibility in capital markets, improve the liquidity of the company's shares, and further increase the company's investment value.